Nov 17, 2021 / 02:30PM GMT
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity Research
Hey, guys. I'm Timothy Anderson. I'm the large-cap pharma and biotech analyst at Wolfe Research. And we're at the start of our healthcare conference that runs today and tomorrow. We'll be talking with AbbVie next here for about the next 40 minutes or so, 3 members of the management team: Mike Severino, who's Vice Chairman and President, heads up R&D, among other things. He has been with the company since 2014. We have Rob Michael, who's EVP and CFO, he's been with the company since 2013; and Jeff Stewart, EVP of Commercial Operations, he's been with the company I think, since 1992, if I got that right; and Liz Shea is somewhere around there as well.
Questions and Answers:
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity ResearchSo I thought we'd start with some general questions here, and we'll have a wide-ranging discussion, but we'll see what we can get through. But first question, so 2021 coming to an end, 6 weeks left. How is the setup for 2022 looking for AbbVie? I
Trustpilot
